1. Clinical Overview
Risperidone is a second-generation (atypical) antipsychotic medication. It is a benzisoxazole derivative with potent serotonin 5-HT2A and dopamine D2 receptor antagonism. The 0.5mg strength is a low-dose formulation, often used for initiation of therapy, in elderly patients, or for specific conditions like irritability associated with autistic disorder. It is widely used in India for schizophrenia, bipolar mania, and other behavioral disturbances.
| Onset | Duration | Bioavailability |
|---|---|---|
| Pharmacological effects begin within hours, but full therapeutic benefit for psychosis may take 1-2 weeks to several weeks. | 24 hours, allowing for once or twice-daily dosing. | 70% (oral). |
2. Mechanism of Action
Risperidone exerts its antipsychotic effect through a combination of potent antagonism of dopamine D2 receptors and serotonin 5-HT2A receptors in the central nervous system. The higher ratio of 5-HT2A to D2 antagonism is thought to contribute to its 'atypical' profile, reducing the risk of extrapyramidal symptoms (EPS) at therapeutic doses compared to typical antipsychotics.
3. Indications & Uses
- Schizophrenia (acute and maintenance treatment)
- Acute manic or mixed episodes associated with Bipolar I Disorder (as monotherapy or adjunct to lithium/valproate)
- Irritability associated with Autistic Disorder in children and adolescents (aged 5-16 years)
4. Dosage & Administration
Adult Dosage: Schizophrenia/Bipolar Mania: Start at 1-2 mg/day in 1 or 2 divided doses. May increase gradually at intervals of ≥24 hours by 0.5-1 mg/day. Usual effective range: 2-6 mg/day. The 0.5mg tablet is used for initial titration or low-dose maintenance.
Administration: May be taken with or without food. Swallow tablet whole with water. The 0.5mg tablet is often scored and can be split for precise titration. Administer once or twice daily as prescribed. Avoid abrupt discontinuation; taper gradually.
5. Side Effects
Common side effects may include:
- Insomnia, agitation, anxiety
- Headache, dizziness
- Sedation/somnolence
- Increased appetite, weight gain
- Nausea, constipation, dyspepsia
- Rhinitis, upper respiratory tract infection
- Hyperprolactinemia (leading to galactorrhea, gynecomastia, menstrual irregularities, sexual dysfunction)
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Carbamazepine, Phenytoin, Rifampicin | Induce CYP450 enzymes, decreasing risperidone plasma levels. Dose adjustment needed. | Major |
| Fluoxetine, Paroxetine, Quinidine | Potent CYP2D6 inhibitors, increase risperidone plasma levels. Reduce risperidone dose. | Major |
| Clozapine | May decrease risperidone clearance, increasing levels. | Moderate |
| Levodopa, Dopamine Agonists | Risperidone antagonizes their effects, reducing efficacy. | Moderate |
| Antihypertensives | Enhanced hypotensive effect. | Moderate |
| CNS Depressants (Alcohol, Benzodiazepines, Opioids) | Additive sedation and respiratory depression. | Major |
| Drugs prolonging QT interval (Class Ia/III antiarrhythmics, certain antibiotics, TCAs) | Additive risk of QT prolongation and torsades de pointes. | Major |
7. Patient Counselling
- DO take exactly as prescribed by your doctor. DO NOT stop suddenly.
- DO inform all your doctors and dentists you are taking risperidone.
- DO report any unusual movements, fever, muscle stiffness, or change in heartbeat immediately.
- DO NOT drink alcohol while on this medication.
- DO NOT drive or operate heavy machinery until you know how the medicine affects you.
- DO get regular monitoring of weight, blood sugar, and lipid profile as advised.
8. Toxicology & Storage
Overdose: Symptoms are an extension of pharmacologic effects: Severe sedation, tachycardia, hypotension, EPS, QT prolongation, seizures. In massive overdose, neuroleptic malignant syndrome (NMS) and respiratory depression are possible.
Storage: Store below 30°C, protected from light and moisture. Keep in the original blister pack or container. Keep out of reach of children and pets. Do not use after the expiry date printed on the pack.